Search for Universal Extra Dimensions in p(p)over-bar Collisions

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Measurements of WW and WZ Production in W plus jets Final States in p(p)over-bar Collisions

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Improved determination of the width of the top quark

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Model indedpendent search for new phenomena in p(p)over-bar collisions at root s=1.96 TeV

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Measurement of the WZ and ZZ production cross sections using leptonic final states in 8.6 fb(-1) of p(p)over-bar collisions

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Measurement of the top-quark mass in p(p)over-bar collisions using events with two leptons

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

A critical investigation of the Tanford-Kirkwood scheme by means of Monte Carlo simulations

Monte Carlo simulations are used to assess the adequacy of the Tanford-Kirkwood prescription for electrostatic interactions in macromolecules. Within a continuum dielectric framework, the approach accurately describes salt screening of electrostatic interactions for moderately charged systems consistent with common proteins at physiological conditions. The limitations of the Debye-Huckel theory, which forms the statistical mechanical basis for the Tanford-Kirkwood result, become apparent for highly charged systems. It is shown, both by an analysis of the Debye-Huckel theory and by numerical simulations, that the difference in dielectric permittivity between macromolecule and surrounding solvent does not play a significant role for salt effects if the macromolecule is highly charged. By comparison to experimental data, the continuum dielectric model (combined with either an approximate effective Hamiltonian as in the Tanford-Kirkwood treatment or with exact Monte Carlo simulations) satisfactorily predicts the effects of charge mutation on metal ion binding constants, but only if the macromolecule and solvent are assigned the same or similar permittivities.

Measurement of the differential cross section d sigma/dt in elastic p(p)over-bar scattering at root s=1.96 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Search for the flavor-changing neutral current decay Bs 0 → μ+ μ- pp̄ Collisions at √s = 1.96 TeV with the DO Detector

We present the results of a search for the flavor-changing neutral current decay Bs 0 → μ+ μ-. using a data set with integrated luminosity of 240 pb-1 of pp̄ collisions at √s = 1.96 TeV collected with the D0 detector in run II of the Fermilab Tevatron collider. We find the upper limit on the branching fraction to be B(Bs 0 → μ+ π-) ≤ 5.0 × 10-7 at the 95% C.L. assuming no contributions from the decay Bd 0 → μ+ μ- in the signal region. This limit is the most stringent upper bound on the branching fraction Bs 0 → μ+ μ- to date. © 2005 The American Physical Society.

Measurement of the pp(-)-> W gamma plus X cross section at root s=1.96 TeV and WW gamma anomalous coupling limits

The WWγ triple gauge boson coupling parameters are studied using pp̄rarr; νγ+X(=e,μ) events at s=1.96 TeV. The data were collected with the D0 detector from an integrated luminosity of 162pb-1 delivered by the Fermilab Tevatron Collider. The cross section times branching fraction for pp̄→W(γ)+X→ νγ+X with ETγ>8 GeV and ΔR γ> 0.7 is 14.8±1.6(stat)±1.0(syst) ±1.0(lum)pb. The one-dimensional 95% confidence level limits on anomalous couplings are -0.88<Δκγ<0.96 and -0. 20<λγ<0.20. © 2005 The American Physical Society.

Measurement of the tt̄ production cross section in pp̄ collisions at √s = 1.96 TeV in dilepton final states

We present a measurement of the top quark pair (tt̄) production cross section in pp̄ collisions at √s=1.96 TeV using events with two charged leptons in the final state. This analysis utilizes an integrated luminosity of 224-243 pb-1 collected with the DØ detector at the Fermilab Tevatron Collider. We observe 13 events in the e+e -, eμ and μ+μ- channels with an expected background of 3.2±0.7 events. For a top quark mass of 175 GeV, we measure a tt̄ production cross section of σtt̄=8. 6-2.7 +3.2(stat)±1.1(syst)±0.6(lumi) pb, consistent with the standard model prediction. © 2005 Elsevier B.V. All rights reserved.

Search for squarks and gluinos in events with jets and missing transverse energy in p(p)over-bar collisions at root s-=1.96 TeV

The results of a search for squarks and gluinos using data from p over(p, ̄) collisions recorded at a center-of-mass energy of 1.96 TeV by the DØ detector at the Fermilab Tevatron Collider are reported. The topologies analyzed consist of acoplanar-jet and multijet events with large missing transverse energy. No evidence for the production of squarks or gluinos was found in a data sample of 310 pb-1. Lower limits of 325 and 241 GeV were derived at the 95% C.L. on the squark and gluino masses, respectively, within the framework of minimal supergravity with tan β = 3, A0 = 0, and μ < 0. © 2006 Elsevier B.V. All rights reserved.

Search for associated Higgs boson production WH→WWW *→l±νl′±ν′+X in pp̄ collisions at s=1.96TeV

We present a search for associated Higgs boson production in the process pp̄→WH→WWW*→l±νl′±ν′ +X in final states containing two like-sign isolated electrons or muons (e±e±, e±μ±, or μ±μ±). The search is based on D0 run II data samples corresponding to integrated luminosities of 360-380pb-1. No excess is observed over the predicted standard model background. We set 95% C.L. upper limits on σ(pp̄→WH) ×Br(H→WW*) between 3.2 and 2.8 pb for Higgs boson masses from 115 to 175 GeV. © 2006 The American Physical Society.

The effect of CpG-ODN on antigen presenting cells of the foal

Background: Cytosine-phosphate-guanosine oligodeoxynucleotide (CpG-ODN) has been used successfully to induce immune responses against viral and intracellular organisms in mammals. The main objective of this study was to test the effect of CpG-ODN on antigen presenting cells of young foals. Methods: Peripheral blood monocytes of foals (n = 7) were isolated in the first day of life and monthly thereafter up to 3 months of life. Adult horse (n = 7) monocytes were isolated and tested once for comparison. Isolated monocytes were stimulated with IL-4 and GM-CSF (to obtain dendritic cells, DC) or not stimulated (to obtain macrophages). Macrophages and DCs were stimulated for 14-16 hours with either CpG-ODN, LPS or not stimulated. The stimulated and non-stimulated cells were tested for cell surface markers (CD86 and MHC class II) using flow cytometry, mRNA expression of cytokines (IL-12, IFNα, IL-10) and TLR-9 using real time quantitative RT-PCR, and for the activation of the transcription factor NF-κB p65 using a chemiluminescence assay. Results: The median fluorescence of the MHC class II molecule in non-stimulated foal macrophages and DCs at birth were 12.5 times and 11.2 times inferior, respectively, than adult horse cells (p = 0.009). That difference subsided at 3 months of life (p = 0.3). The expression of the CD86 co-stimulatory molecule was comparable in adult horse and foal macrophages and DCs, independent of treatment. CpG-ODN stimulation induced IL-12p40 (53 times) and IFNα (23 times) mRNA expression in CpG-ODN-treated adult horse DCs (p = 0.078), but not macrophages, in comparison to non-stimulated cells. In contrast, foal APCs did not respond to CpG-ODN stimulation with increased cytokine mRNA expression up to 3 months of age. TLR-9 mRNA expression and NF-kB activation (NF-kB p65) in foal DCs and macrophages were comparable (p > 0.05) to adult horse cells. Conclusion: CpG-ODN treatment did not induce specific maturation and cytokine expression in foal macrophages and DCs. Nevertheless, adult horse DCs, but not macrophages, increased their expression of IL-12 and IFNα cytokines upon CpG-ODN stimulation. Importantly, foals presented an age-dependent limitation in the expression of MHC class II in macrophages and DCs, independent of treatment. © 2007 Flaminio et al; licensee BioMed Central Ltd.